Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122227904 | 12222790 | 4 | F | 20160914 | 20160330 | 20160921 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-020922 | BRISTOL MYERS SQUIBB | 83.00 | YR | F | Y | 0.00000 | 20160921 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122227904 | 12222790 | 1 | PS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, Q4WK | 125118 | 750 | MG | SOLUTION FOR INFUSION | |||||||
122227904 | 12222790 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100 MG, BID | U | 0 | 100 | MG | BID | ||||||
122227904 | 12222790 | 3 | SS | CELEBREX | CELECOXIB | 1 | Oral | 0 | CAPSULE | ||||||||||
122227904 | 12222790 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 488 MG, QMO | U | 0 | 488 | MG | /month | ||||||
122227904 | 12222790 | 5 | SS | FENTANYL. | FENTANYL | 1 | Unknown | U | 0 | ||||||||||
122227904 | 12222790 | 6 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | TABLET | |||||||||
122227904 | 12222790 | 7 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 0 | 50 | MG | /wk | ||||||
122227904 | 12222790 | 8 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | UNK, QWK | U | 0 | /wk | ||||||||
122227904 | 12222790 | 9 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 2.5 G, QD | U | 0 | 2.5 | G | QD | ||||||
122227904 | 12222790 | 10 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | 400 MG, QD | U | 0 | 400 | MG | TABLET | QD | |||||
122227904 | 12222790 | 11 | SS | MYOCHRYSINE | GOLD SODIUM THIOMALATE | 1 | Intramuscular | 50 MG, Q3WK | U | 0 | 50 | MG | Q3W | ||||||
122227904 | 12222790 | 12 | C | OMEGA 3 /01333901/ | FISH OILTOCOPHEROL | 1 | Unknown | 1200 MG, BID | U | 0 | 1200 | MG | BID | ||||||
122227904 | 12222790 | 13 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | Unknown | U | 0 | ||||||||||
122227904 | 12222790 | 14 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
122227904 | 12222790 | 15 | C | DIPHENOXYLATE | DIPHENOXYLATE | 1 | Unknown | 2.5 MG, UNK | U | 0 | 2.5 | MG | QD | ||||||
122227904 | 12222790 | 16 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | 400 UNIT, UNK | U | 0 | 400 | DF | QD | ||||||
122227904 | 12222790 | 17 | C | ACTONEL | RISEDRONATE SODIUM | 1 | Unknown | 36 MG, QWK | U | 0 | 36 | MG | /wk | ||||||
122227904 | 12222790 | 18 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
122227904 | 12222790 | 19 | C | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 750 MG, Q4WK | U | 0 | 750 | MG | |||||||
122227904 | 12222790 | 20 | C | CALCIUM | CALCIUM | 1 | Unknown | U | 0 | ||||||||||
122227904 | 12222790 | 21 | C | ACETAMINOPHEN W/OXYCODONE HYDROCHLORIDE | 2 | Unknown | 1 DF, PRN | U | 0 | 1 | DF | ||||||||
122227904 | 12222790 | 22 | C | BIOTIN W/CALCIUM PANTOTHENATE/COLEC/06004901/ | 2 | Unknown | U | 0 | |||||||||||
122227904 | 12222790 | 23 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | 400 IU, QD | U | 0 | 400 | IU | QD | ||||||
122227904 | 12222790 | 24 | C | ESOMEPRAZOLE /01479302/ | ESOMEPRAZOLE | 1 | Unknown | 40 MG, BID | U | 0 | 40 | MG | TABLET | BID | |||||
122227904 | 12222790 | 25 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
122227904 | 12222790 | 26 | C | LOPERAMIDE HYDROCHLORIDE. | LOPERAMIDE HYDROCHLORIDE | 1 | Unknown | 2.5 MG, UNK | U | 0 | 2.5 | MG | |||||||
122227904 | 12222790 | 27 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 2 DF, BID | U | 0 | 2 | DF | BID | ||||||
122227904 | 12222790 | 28 | C | NORTRIPTYLINE HYDROCHLORIDE W/PERPHENAZINE | 2 | Oral | 10 MG, UNK | U | 0 | 10 | MG | ||||||||
122227904 | 12222790 | 29 | C | PANTOPRAZOLE MAGNESIUM | PANTOPRAZOLE MAGNESIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
122227904 | 12222790 | 30 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | QD | ||||||
122227904 | 12222790 | 31 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 1000 MG, QD | U | 0 | 1000 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122227904 | 12222790 | 1 | Rheumatoid arthritis |
122227904 | 12222790 | 2 | Product used for unknown indication |
122227904 | 12222790 | 3 | Arthritis |
122227904 | 12222790 | 4 | Rheumatoid arthritis |
122227904 | 12222790 | 5 | Product used for unknown indication |
122227904 | 12222790 | 6 | Product used for unknown indication |
122227904 | 12222790 | 7 | Rheumatoid arthritis |
122227904 | 12222790 | 8 | Rheumatoid arthritis |
122227904 | 12222790 | 9 | Rheumatoid arthritis |
122227904 | 12222790 | 10 | Rheumatoid arthritis |
122227904 | 12222790 | 11 | Rheumatoid arthritis |
122227904 | 12222790 | 12 | Product used for unknown indication |
122227904 | 12222790 | 13 | Product used for unknown indication |
122227904 | 12222790 | 14 | Product used for unknown indication |
122227904 | 12222790 | 15 | Product used for unknown indication |
122227904 | 12222790 | 16 | Product used for unknown indication |
122227904 | 12222790 | 17 | Product used for unknown indication |
122227904 | 12222790 | 18 | Product used for unknown indication |
122227904 | 12222790 | 19 | Product used for unknown indication |
122227904 | 12222790 | 20 | Product used for unknown indication |
122227904 | 12222790 | 21 | Pain |
122227904 | 12222790 | 22 | Product used for unknown indication |
122227904 | 12222790 | 23 | Product used for unknown indication |
122227904 | 12222790 | 24 | Product used for unknown indication |
122227904 | 12222790 | 25 | Product used for unknown indication |
122227904 | 12222790 | 26 | Product used for unknown indication |
122227904 | 12222790 | 27 | Product used for unknown indication |
122227904 | 12222790 | 28 | Sleep disorder |
122227904 | 12222790 | 29 | Product used for unknown indication |
122227904 | 12222790 | 30 | Product used for unknown indication |
122227904 | 12222790 | 31 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122227904 | 12222790 | OT |
122227904 | 12222790 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122227904 | 12222790 | Blood creatinine increased | |
122227904 | 12222790 | Cyst | |
122227904 | 12222790 | Deafness neurosensory | |
122227904 | 12222790 | Diarrhoea | |
122227904 | 12222790 | Drug ineffective | |
122227904 | 12222790 | Drug intolerance | |
122227904 | 12222790 | Dry eye | |
122227904 | 12222790 | Epigastric discomfort | |
122227904 | 12222790 | Fatigue | |
122227904 | 12222790 | Gastrointestinal disorder | |
122227904 | 12222790 | Infection | |
122227904 | 12222790 | Nausea | |
122227904 | 12222790 | Osteoarthritis | |
122227904 | 12222790 | Osteopenia | |
122227904 | 12222790 | Pleural fibrosis | |
122227904 | 12222790 | Presbyacusis | |
122227904 | 12222790 | Renal impairment | |
122227904 | 12222790 | Skin lesion | |
122227904 | 12222790 | Sleep disorder | |
122227904 | 12222790 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122227904 | 12222790 | 1 | 20150331 | 20160223 | 0 |